Literature DB >> 26484428

Mother-to-child Transmission of HIV From 1999 to 2011 in the Amazonas, Brazil: Risk Factors and Remaining Gaps in Prevention Strategies.

Solange Dourado de Andrade1, Meritxell Sabidó, Wuelton Marcelo Monteiro, Luiz Canellas, Vania Prazeres, Adele Schwartz Benzaken.   

Abstract

BACKGROUND: The purpose of the study was to estimate rates of mother-to-child transmission (MTCT) of HIV in the Amazonas, Brazil, and to identify the associated factors.
METHODS: This was a retrospective cohort study of 1210 children born to HIV-infected women between 1999 and 2011 and enrolled before age of 18 months in a reference HIV/AIDS pediatrics service in Manaus. We used multivariable logistic regression to assess the effect of maternal, obstetric and prophylactic interventions on MTCT of HIV.
RESULTS: Ten children were excluded because of undocumented maternal HIV status. Among 1200 children, 163 (13.6%) were lost to follow-up. We included in the analysis 1037 children with known HIV status. Of those, 68 children were HIV infected, resulting in a MTCT rate of 6.6% [95% confidence interval (CI): 5.3-8.3]. Among mothers, 76.1% had received antiretroviral therapy during pregnancy, 59.3% elective caesarean, and 9.7% were breastfed. Factors associated with lower odds of MTCT of HIV were antiretroviral therapy during pregnancy [odds ratio (OR): 0.26; 95% CI: 0.12-0.58], elective caesarean (OR: 0.48; 95% CI: 0.23-0.98) and with MTCT: being breastfed (OR: 4.56; 95% CI: 2.19-9.50). Transmission decreased from 7.5% in 2007-2008 to 3.2% in 2011, while breastfeeding decreased from 30.8% in 1999-2000 to 3.9% in 2011-2012.
CONCLUSIONS: The HIV rate of MTCT is still high in the Amazonas and challenges for its prevention prevail including lost to follow-up and gaps in critical strategies such as antiretroviral use during pregnancy. More efforts are needed to increase the number of women and babies who successfully complete the prevention of MTCT cascade and work toward elimination of MTCT of HIV.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26484428     DOI: 10.1097/INF.0000000000000966

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

Review 1.  Review of the missed opportunities for the prevention of vertical transmission of HIV in Brazil.

Authors:  Mariana Fernandes Guimarães; Kathryn Lynn Lovero; Juliana Gregório de Avelar; Laís Lopes Pires; Giovanna Rodrigues Teixeira de Oliveira; Estela Magalhães Cosme; Camila de Morais Salviato; Thais Raquelly Dourado de Oliveira; Natália Beatriz Cabrera; Claudete Aparecida Araújo Cardoso
Journal:  Clinics (Sao Paulo)       Date:  2019-09-16       Impact factor: 2.898

2.  Mother-to-Child Transmission of HIV and Associated Factors Among Exposed Infants in Pastoralist Health Facilities, South Omo Zone, Ethiopia, 2020 - A Retrospective Cross-Sectional Study.

Authors:  Kidist Tadewos; Mekonen Adimasu; Erdaw Tachbele
Journal:  HIV AIDS (Auckl)       Date:  2021-12-09

3.  Retrospective analysis of risk factors and gaps in prevention strategies for mother-to-child HIV transmission in Rio de Janeiro, Brazil.

Authors:  Kathryn Lynn Lovero; Thais Raquelly Dourado de Oliveira; Estela Magalhães Cosme; Natália Beatriz Cabrera; Mariana Fernandes Guimarães; Juliana Gregório de Avelar; Giovanna Rodrigues Teixeira de Oliveira; Camila de Morais Salviato; Guillermo Douglass-Jaimes; Maria Leticia Santos Cruz; Esaú Custódio João; Ana Cláudia Mamede Wiering de Barros; Marcos Vinicius da Silva Pone; Ivete Martins Gomes; Lee Woodland Riley; Claudete Aparecida Araújo Cardoso
Journal:  BMC Public Health       Date:  2018-09-10       Impact factor: 3.295

4.  High vertical HIV transmission rate in the Midwest region of Brazil.

Authors:  Vanessa Terezinha Gubert de Matos; Fabiani de Morais Batista; Naiara Valera Versage; Clarice Souza Pinto; Vanessa Marcon de Oliveira; Érica Freire de Vasconcelos-Pereira; Roberta Barbeta Dos Rios de Matos; Márcia Maria Ferrairo Janini Dal Fabbro; Ana Lúcia Lyrio de Oliveira
Journal:  Braz J Infect Dis       Date:  2018-05-09       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.